148 related articles for article (PubMed ID: 21046979)
1. Synthesis, biological evaluation and molecular docking of aryl hydrazines and hydrazides for anticancer activity.
Gohil VM; Agrawal SK; Saxena AK; Garg D; Gopimohan C; Bhutani KK
Indian J Exp Biol; 2010 Mar; 48(3):265-8. PubMed ID: 21046979
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of hydrazidomycin analogues.
Meyer F; Ueberschaar N; Dahse HM; Hertweck C
Bioorg Med Chem Lett; 2013 Nov; 23(22):6043-5. PubMed ID: 24113061
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
Onnis V; Cocco MT; Fadda R; Congiu C
Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483
[TBL] [Abstract][Full Text] [Related]
7. The effect of 5-substitution in the pyrimidine ring of dUMP on the interaction with thymidylate synthase: molecular modeling and QSAR.
Jarmuła A; Cieplak P; Krygowski TM; Rode W
Bioorg Med Chem; 2007 Mar; 15(6):2346-58. PubMed ID: 17275316
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of analogues of butyrolactone I and molecular model of its interaction with CDK2.
Braña MF; García ML; López B; de Pascual-Teresa B; Ramos A; Pozuelo JM; Domínguez MT
Org Biomol Chem; 2004 Jul; 2(13):1864-71. PubMed ID: 15227538
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
[TBL] [Abstract][Full Text] [Related]
10. Cyanoacetic acid hydrazones of 3-(and 4-)acetylpyridine and some derived ring systems as potential antitumor and anti-HCV agents.
El-Hawash SA; Abdel Wahab AE; El-Demellawy MA
Arch Pharm (Weinheim); 2006 Jan; 339(1):14-23. PubMed ID: 16411172
[TBL] [Abstract][Full Text] [Related]
11. Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
Jourdan F; Bubert C; Leese MP; Smith A; Ferrandis E; Regis-Lydi S; Newman SP; Purohit A; Reed MJ; Potter BV
Org Biomol Chem; 2008 Nov; 6(22):4108-19. PubMed ID: 18972041
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents.
Kamal A; Khan MN; Srinivasa Reddy K; Rohini K
Bioorg Med Chem; 2007 Jan; 15(2):1004-13. PubMed ID: 17097292
[TBL] [Abstract][Full Text] [Related]
15. Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins.
Shrestha AR; Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Oct; 16(20):9161-70. PubMed ID: 18819815
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
Singh P; Kaur M; Verma P
Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
[TBL] [Abstract][Full Text] [Related]
18. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of novel heterocycles as anticancer agents.
Chauhan PM; Martins CJ; Horwell DC
Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
